Givaudan SA (OTCMKTS:GVDNY - Get Free Report) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totaling 900 shares, a decrease of 64.0% from the August 31st total of 2,500 shares. Based on an average daily volume of 322,100 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 322,100 shares, the days-to-cover ratio is presently 0.0 days.
Analyst Upgrades and Downgrades
GVDNY has been the subject of several recent research reports. Barclays upgraded shares of Givaudan from a "strong sell" rating to a "hold" rating in a research note on Tuesday, July 8th. Jefferies Financial Group raised Givaudan from a "moderate sell" rating to a "hold" rating in a report on Friday, September 12th. One analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy".
Check Out Our Latest Stock Report on GVDNY
Givaudan Stock Performance
Shares of OTCMKTS GVDNY traded up $0.18 during trading on Thursday, reaching $81.05. The company had a trading volume of 9,316 shares, compared to its average volume of 38,403. The stock has a 50-day moving average price of $84.39 and a two-hundred day moving average price of $91.27. Givaudan has a twelve month low of $79.46 and a twelve month high of $105.60. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.85 and a current ratio of 1.38.
About Givaudan
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.